Table 3.
Treatments before and after first consultation with diagnosis of interest
| Before first consultation with diagnosis of interest | After first consultation with diagnosis of interest | ||||
|---|---|---|---|---|---|
| n | (%) | n | (%) | p-value | |
| PPA patients | |||||
| Pharmacological treatments | |||||
| Antidepressant | 330 | (20.4) | 629 | (38.8) | <.001 |
| Anxiolytic | 130 | (8.0) | 237 | (14.6) | <.001 |
| Hypnotic | 64 | (4.0) | 94 | (5.8) | <.001 |
| Neuroleptic | 29 | (1.8) | 116 | (7.2) | <.001 |
| NMDA antagonist | 77 | (4.8) | 306 | (18.9) | <.001 |
| ChEI | 144 | (8.9) | 426 | (26.3) | <.001 |
| Non-pharmacological treatments | |||||
| Day hospital | 24 | (1.5) | 158 | (9.8) | <.001 |
| Speech and language therapist (SLT) | 365 | (22.7) | 1060 | (66.0) | <.001 |
| Psychologist | 66 | (4.1) | 130 | (8.1) | <.001 |
| Kinesiologist | 35 | (2.2) | 169 | (10.5) | <.001 |
| Occupational therapist | 17 | (1.1) | 50 | (3.1) | <.001 |
| Stakeholder group | 24 | (1.5) | 84 | (5.2) | <.001 |
| AD patients | |||||
| Pharmacological treatments | |||||
| Antidepressant | 10,261 | (24.1) | 16,528 | (38.8) | <.001 |
| Anxiolytic | 5226 | (12.3) | 8626 | (20.3) | <.001 |
| Hypnotic | 2375 | (5.6) | 3380 | (7.9) | <.001 |
| Neuroleptic | 1359 | (3.2) | 3943 | (9.3) | <.001 |
| NMDA antagonist | 1801 | (4.2) | 11,670 | (27.4) | <.001 |
| ChEI | 5967 | (14.0) | 24,927 | (58.6) | <.001 |
| Non-pharmacological treatments | |||||
| Day hospital | 628 | (1.5) | 5272 | (12.7) | <.001 |
| Speech and language therapist (SLT) | 2,785 | (6.7) | 8807 | (21.2) | <.001 |
| Psychologist | 1214 | (2.9) | 2377 | (5.7) | <.001 |
| Kinesiologist | 1562 | (3.8) | 4311 | (10.4) | <.001 |
| Occupational therapist | 658 | (1.6) | 1546 | (3.7) | <.001 |
| Stakeholder group | 941 | (2.3) | 3038 | (7.3) | <.001 |
*McNemar test